Results 191 to 200 of about 5,061,309 (249)

Immune Markers and Risk of Pancreatic Cancer in the European EPIC Cohort

open access: yesInternational Journal of Cancer, Volume 159, Issue 9, Page 2146-2157, 1 November 2026.
The immune system has been implicated as a major driver in pancreatic cancer etiology. Previous cohort studies have found associations between pancreatic cancer and single immune system‐derived markers, but omics‐based evidence remains scarce. In this prospective case–control study, the authors investigated 92 proteins involved in immune reactions and ...
Verena A. Katzke   +28 more
wiley   +1 more source

Correction: understanding the structure of insight in eating disorders: validation of the SAI-ED in a Spanish clinical sample. [PDF]

open access: yesJ Eat Disord
Gawron LP   +10 more
europepmc   +1 more source

Standardized Microplate‐Based Assays for Quantifying Antioxidant Activity in Extracellular Vesicles and Nanovesicles Across Biological Kingdoms

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 11, November 2026.
ABSTRACT The antioxidant activity of extracellular vesicles (EVs) and nanovesicles are increasingly linked to their physiological and therapeutic functions, yet its accurate quantification remains limited by low EV yield, co‐isolated contaminants and the lack of standardized methodologies.
Juan Antonio Nieto   +15 more
wiley   +1 more source

Scaling of an evidence-based intervention program in older people with diabetes and frailty in Latin America. Diabfrail-Latam clinical trial protocol. [PDF]

open access: yesJ Frailty Aging
Laosa O   +20 more
europepmc   +1 more source

Ética de la investigación biomédica

open access: yesArbor: Ciencia, Pensamiento y Cultura, 2008
David Rodríguez-Arias
doaj  

Fatty Acid Oxidation Disorders Detected by Newborn Screening: Clinical, Biochemical and Genetic Spectrum in a Single‐Center Cohort

open access: yesJIMD Reports, Volume 67, Issue 6, November 2026.
ABSTRACT Newborn screening (NBS) has significantly improved early detection and survival in fatty acid oxidation disorders (FAODs). However, the expanding phenotypic spectrum challenges prognostic stratification, and long‐term morbidity remains incompletely characterized.
Elena Martín‐Hernández   +10 more
wiley   +1 more source

Temporal Trends in Janus Kinase Inhibitor (JAKi) Use Across Five European Countries: A DARWIN EU Network Study

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Introduction Janus kinase inhibitors (JAKi) are increasingly used for autoimmune conditions despite existing safety concerns. This study aims to estimate the incidence of new JAKi use over time and characterise users in Europe to support future safety studies.
Xihang Chen   +14 more
wiley   +1 more source

Corrigendum to "Influence of coffee roasting degree on antioxidant and metabolic parameters: Comprehensive in vitro and in vivo analysis" [Curr. Res. Food Sci. 9 (2024) 100861]. [PDF]

open access: yesCurr Res Food Sci
Gamboa-Gómez CI   +9 more
europepmc   +1 more source

Intestinal Permeability in Irritable Bowel Syndrome With and Without Comorbid Conditions: Results From the European DISCOvERIE Cohort

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 9, November 2026.
ABSTRACT Background Irritable bowel syndrome (IBS) is a disorder of gut‐brain interaction often accompanied by psychiatric and/or somatic comorbidities. Intestinal‐barrier dysfunction has been implicated in IBS pathophysiology. However, the contribution of psychiatric and somatic comorbidities to intestinal permeability remains unclear.
Alice Rustichelli   +33 more
wiley   +1 more source

Impact of Prior Biologic Mechanism of Action on Anti‐TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 9, Page 1234-1247, November 2026.
In this nationwide ENEIDA registry study, anti‐TNF therapy after prior exposure to a different biologic mechanism of action showed reduced treatment durability in inflammatory bowel disease, with a particularly marked impact in ulcerative colitis, where short‐ and long‐term clinical effectiveness was also lower. ABSTRACT Background The expanding use of
Carmen Yagüe Caballero   +85 more
wiley   +1 more source

Home - About - Disclaimer - Privacy